ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,272.46
0.82%
Dow Jones
39,134.76
0.77%
Gold vs US Dollar
2,364.30
0.14%
Brent Oil
84.965
-0.05%
Bitcoin
64,598.57
-0.34%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oramed Pharmaceuticals Inc (ORMP)

  7. Oramed Pharmaceuticals Inc (ORMP) News

Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORMP
DateTimeSourceHeadlineSymbolCompany
20/06/202412:32Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ORMPOramed Pharmaceuticals Inc
20/06/202412:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ORMPOramed Pharmaceuticals Inc
10/06/202422:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
10/06/202422:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
09/05/202422:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORMPOramed Pharmaceuticals Inc
06/05/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
19/03/202413:00GlobeNewswire Inc.Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and InnovationNASDAQ:ORMPOramed Pharmaceuticals Inc
06/03/202422:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ORMPOramed Pharmaceuticals Inc
20/02/202413:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
20/02/202413:30PR Newswire (US)Oramed Letter to ShareholdersNASDAQ:ORMPOramed Pharmaceuticals Inc
30/01/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
23/01/202421:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
19/01/202421:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
08/01/202421:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
08/01/202421:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
08/01/202421:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
08/01/202421:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
08/01/202421:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
08/01/202421:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
08/01/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
08/01/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
08/01/202421:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
08/01/202421:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
08/01/202421:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
02/01/202418:13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
21/12/202314:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
18/12/202321:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
09/11/202322:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORMPOramed Pharmaceuticals Inc
26/09/202321:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
22/09/202316:38PR Newswire (US)Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding CompanyNASDAQ:ORMPOramed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ORMP

Your Recent History

USOTC
GZITF
Yuexiu Transport Infrast... (PK)
NYSE
WHZ
ASX
OSHSWR
ASX
URF
Us Masters Residential P...
TSXV
COE
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved